Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion - PubMed (original) (raw)
Activation of Toll-like receptor 4 signaling contributes to hippocampal neuronal death following global cerebral ischemia/reperfusion
Fang Hua et al. J Neuroimmunol. 2007 Oct.
Abstract
Toll-like receptors (TLRs) play a critical role in the induction of innate immune responses which have been implicated in neuronal death induced by global cerebral ischemia/reperfusion (GCI/R). The present study investigated the role and mechanisms-of-action of TLR4 signaling in ischemia-induced hippocampal neuronal death. Neuronal damage, activation of the TLR4 signaling pathway, expression of pro-inflammatory cytokines and activation of the PI3K/Akt signaling pathway in the hippocampal formation (HF) were assessed in wild type (WT) mice and TLR4 knockout (TLR4(-/-)) mice after GCI/R. GCI/R increased expression of TLR4 protein in the hippocampal formation (HF) and other brain structures in WT mice. Phosphorylation of the inhibitor of kappa B (p-IkappaB) as well as activation of nuclear factor kappa B (NFkappaB) increased in the HF of WT mice. In contrast, there were lower levels of p-IkappaB and NFkappaB binding activity in TLR4(-/-) mice subjected to GCI/R. Pro-inflammatory cytokine expression was also decreased, while phosphorylation of Akt and GSK3beta were increased in the HF of TLR4(-/-) mice after GCI/R. These changes correlated with decreased neuronal death/apoptosis in TLR4(-/-) mice following GCI/R. These data suggest that activation of TLR4 signaling contributes to ischemia-induced hippocampal neuronal death. In addition, these data suggest that modulation of TLR4 signaling may attenuate ischemic injury in hippocampal neurons.
Figures
Figure 1. TLR4 deficient mice show decreased neuronal damage in the HF after GCI/R
Brain sections were stained with 0.1% cresyl violet. Viable neurons were defined as neurons in which a normal nucleus can be seen. Damaged neurons exhibit features including pyknosis, karyorhexis and shrunken cell bodies. Three days after GCI/R, neuronal damage was prominent in the CA1 and dentate gyrus (DG) of the HF in WT mice. Compared with WT mice, there was less neuronal damage in the HF of TLR4-/- mice. A, D and G: HF; B, E and H: CA1; C, F and I: dentate gyrus (DG). WT-S: wild type sham, WT-I/R: wild type subjected to GCI/R, TLR4-/- -I/R: TLR4-/- mice subjected to GCI/R.
Figure 2. TLR4 deficiency results in decreased neuronal apoptosis in the HF in response to GCI/R
Neuronal apoptosis was confirmed by the methods of TUNEL staining (A to F) and IHC staining for cleaved caspase-3, a specific marker of apoptosis (G to L). The positive staining was shown in brown. Slides were counterstained with hematoxylin. Results show that GCI/R results in increased numbers of TUNEL positive cells in the HF (B and E) in WT mice. In TLR4-/--I/R mice, there were fewer TUNEL positive staining cells in the HF (C and F) compared with WT-I/R mice (M, # p < 0.05). GCI/R results in the expression of cleaved caspase-3 in the DG area of the HF in WT mice three days after GCI/R (K). There was less expression of cleaved caspase-3 in the DG in TLR4-/--I/R mice (L) compared with WT-I/R mice (N, # p < 0.01). In both WT and TLR4-/- mice, there was only light positive staining for cleaved caspase-3 in the CA1 of the HF three days after GCI/R (H and I). A, B, C, G, H and I: CA1; D, E, F, J, K and L: dentate gyrus (DG) of the HF. WT-S: wild type sham, WT-I/R: wild type subjected to GCI/R, TLR4-/- -I/R: TLR4-/- mice subjected to GCI/R.
Figure 3. TLR4 expression in WT mice is increased in brain tissue after GCI/R
Brain tissue sections were stained by IHC, TLR4 immunoreactivity was indicated by the presence of a brown color. Tissue sections were counterstained with hematoxylin. Results showed that there was no TLR4 expression observed in sham operated WT mice (WT-S) (A). Expression of TLR4 was observed in WT mice brain (B) after GCI/R in the caudate-putamen (CPu, D), CA1 (E), dentate gyrus (DG, F) and cortex (G). WT-S: wild type sham, WT-I/R: wild type subjected to GCI/R. No TLR4 immunoreactivity was observed in TLR4-/- mice subjected to GCI/R (C).
Figure 4. Decreased nuclear translocation of phospho-NFκB p65 in the HF of TLR4-/- mice in response to GCI/R
Phospho-NFκB p65 (p-NFκB p65) immunoreactivity was shown as a brown color by IHC staining. Tissue sections were counterstained with hematoxylin. There was no detectable p-NFκB p65 in sham operated mice (A and D). Nuclear translocation of p-NFκB p65 was increased in the HF of WT mice by GCI/R, shown in CA1 (B) and dentate gyrus (DG, E) (arrows). Less p-NFκB p65 was observed in the CA1 and DG of TLR4-/- mice after GCI/R compared with WT mice (B, C, E and F) (arrows). WT-S: wild type sham, WT-I/R: wild type subjected to GCI/R, TLR4-/- -I/R: TLR4-/- mice subjected to GCI/R.
Figure 5. Decreased NFκB DNA binding activity and increased phosphorylation of IκB in the HF of TLR4-/- mice after GCI/R
EMSA showed that GCI/R results in increased DNA binding activity of NFκB in the HF of WT mice six hours after GCI/R (A, #: compared with WT-S p< 0.05). The level of NFκB activity was less in TLR4-/- mice compared with WT mice six hours after GCI/R (A, *: compared with WT-I/R, p<0.05). Representative EMSA results are shown at the top. Western Blots showed that the level of phosphorylated IκB increased in the HF of WT mice 6 hours after GCI/R compared with WT control (B, #: compared with WT-S, p < 0.05). There was less p- IκB in the HF of TLR4-/- mice compared with WT mice 6 hours after GCI/R (B, *: compared with WT-I/R, p < 0.05). WT-S: wild type sham, WT-I/R: wild type subjected to GCI/R, TLR4-/--S: TLR4-/- sham, TLR4-/- -I/R: TLR4-/- mice subjected to GCI/R. Results are mean ± SE (n=3 in WT-S and TLR4-/--S groups; n=5 in WT-I/R and TLR4-/-I/R groups). Representative results of Western blots are shown at the top.
Figure 6. TLR4 dependent increase in IL-6, TNFα, Fas-L and HMGB1 expression in the HF in response to GCI/R
Western Blots showed that IL-6 (A), TNFα (B), Fas-L (C) and HMGB1 (D) levels were increased in the HF of WT mice 6 hours after GCI/R compared with WT sham control (#: compared with WT-S, p < 0.05). IL-6, TNFα, Fas-L and HMGB1 levels in the HF of TLR4-/- mice were not significantly changed after GCI/R and were lower than that in WT mice after GCI/R (*: compared with WT-I/R, p < 0.05). WT-S: wild type sham, WT-I/R: wild type subjected to GCI/R, TLR4-/--S: TLR4-/- sham, TLR4-/- -I/R: TLR4-/- mice subjected to GCI/R. Results are expressed as ratio of integrated density value (IDV) of individual cytokines vs. IDV of GAPDH, mean ± SE (n=3 in WT-S and TLR4-/--S groups; n=5 in WT-I/R and TLR4-/-I/R groups). Representative results of Western blots are shown at the top of each pane.
Figure 7. TLR4 deficiency results in increased brain phosphorylation of AKt and GSK3β in response GCI/R
Western Blots showed that the levels of phospho-Akt (p-Akt) (A) and phospho-GSK3β (p- GSK3β, B) in the HF of TLR4-/- mice were significantly higher than those in WT mice at 6 hours after GCI/R (*: compared with WT-I/R, p < 0.05; #: compared with WT-S, p < 0.05). WT-S: wild type sham, WT-I/R: wild type subjected to GCI/R, TLR4-/--S: TLR4-/- sham, TLR4-/- -I/R: TLR4-/- mice subjected to GCI/R. Results are expressed as ratio of integrated density value (IDV) of p-Akt vs. IDV of Akt1, and IDV of p- GSK3β vs. GSK3β, mean ± SE (n=3 in WT-S and TLR4-/--S groups; n=5 in WT-I/R and TLR4-/-I/R groups). Representative results of Western blots are shown at the top of each pane.
Similar articles
- Toll-like receptor 4 mediates retinal ischemia/reperfusion injury through nuclear factor-κB and spleen tyrosine kinase activation.
Ishizuka F, Shimazawa M, Inoue Y, Nakano Y, Ogishima H, Nakamura S, Tsuruma K, Tanaka H, Inagaki N, Hara H. Ishizuka F, et al. Invest Ophthalmol Vis Sci. 2013 Aug 27;54(8):5807-16. doi: 10.1167/iovs.13-11932. Invest Ophthalmol Vis Sci. 2013. PMID: 23908181 - Hydroxysafflor yellow A exerts neuroprotective effects in cerebral ischemia reperfusion-injured mice by suppressing the innate immune TLR4-inducing pathway.
Lv Y, Qian Y, Fu L, Chen X, Zhong H, Wei X. Lv Y, et al. Eur J Pharmacol. 2015 Dec 15;769:324-32. doi: 10.1016/j.ejphar.2015.11.036. Epub 2015 Nov 25. Eur J Pharmacol. 2015. PMID: 26607471 - Nobiletin improves propofol-induced neuroprotection via regulating Akt/mTOR and TLR 4/NF-κB signaling in ischemic brain injury in rats.
Zheng Y, Bu J, Yu L, Chen J, Liu H. Zheng Y, et al. Biomed Pharmacother. 2017 Jul;91:494-503. doi: 10.1016/j.biopha.2017.04.048. Epub 2017 May 4. Biomed Pharmacother. 2017. PMID: 28478273 - NF-kappaB signaling in cerebral ischemia.
Ridder DA, Schwaninger M. Ridder DA, et al. Neuroscience. 2009 Feb 6;158(3):995-1006. doi: 10.1016/j.neuroscience.2008.07.007. Epub 2008 Jul 10. Neuroscience. 2009. PMID: 18675321 Review. - Toll-like receptors: new players in myocardial ischemia/reperfusion injury.
Ha T, Liu L, Kelley J, Kao R, Williams D, Li C. Ha T, et al. Antioxid Redox Signal. 2011 Oct 1;15(7):1875-93. doi: 10.1089/ars.2010.3723. Epub 2011 Apr 8. Antioxid Redox Signal. 2011. PMID: 21091074 Free PMC article. Review.
Cited by
- Amelioration of Hepatic Encephalopathy Using Dunaliella salina Microalgae in Rats: Modulation of Hyperammonemia/TLR4.
El-Baz FK, Elgohary R, Salama A. El-Baz FK, et al. Biomed Res Int. 2021 Mar 28;2021:8843218. doi: 10.1155/2021/8843218. eCollection 2021. Biomed Res Int. 2021. PMID: 33855084 Free PMC article. - TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice.
Hua F, Tang H, Wang J, Prunty MC, Hua X, Sayeed I, Stein DG. Hua F, et al. J Cereb Blood Flow Metab. 2015 Mar 31;35(4):536-42. doi: 10.1038/jcbfm.2014.240. J Cereb Blood Flow Metab. 2015. PMID: 25586141 Free PMC article. - Toll-like receptor 4 in CNS pathologies.
Buchanan MM, Hutchinson M, Watkins LR, Yin H. Buchanan MM, et al. J Neurochem. 2010 Jul;114(1):13-27. doi: 10.1111/j.1471-4159.2010.06736.x. Epub 2010 Apr 6. J Neurochem. 2010. PMID: 20402965 Free PMC article. Review. - Ouabain-Na+/K+-ATPase Signaling Regulates Retinal Neuroinflammation and ROS Production Preventing Neuronal Death by an Autophagy-Dependent Mechanism Following Optic Nerve Axotomy In Vitro.
Mázala-de-Oliveira T, de Figueiredo CS, de Rezende Corrêa G, da Silva MS, Miranda RL, de Azevedo MA, Cossenza M, Dos Santos AA, Giestal-de-Araujo E. Mázala-de-Oliveira T, et al. Neurochem Res. 2022 Mar;47(3):723-738. doi: 10.1007/s11064-021-03481-0. Epub 2021 Nov 16. Neurochem Res. 2022. PMID: 34783975 - Protective Effects of Fibroblast Growth Factor 21 Against Amyloid-Beta1-42-Induced Toxicity in SH-SY5Y Cells.
Amiri M, Braidy N, Aminzadeh M. Amiri M, et al. Neurotox Res. 2018 Oct;34(3):574-583. doi: 10.1007/s12640-018-9914-2. Epub 2018 Jun 5. Neurotox Res. 2018. PMID: 29869772
References
- Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature. 2000;406:782–787. - PubMed
- Barone F, Arvin B, White R, Miller A, Webb C, Willette R, Lysko P, Feuerstein G. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke. 1997;28:1233–1244. - PubMed
- Barone F, Feuerstein G. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab. 1999;19:819–834. - PubMed
- Berti R, Williams A, Moffett J, Hale S, Velarde L, Elliott P, Yao C, Dave J, Tortella F. Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury. J Cereb Blood Flow Metab. 2002;22:1068–1079. - PubMed
- Bottcher T, Von Mering M, Ebert S, Meyding-Lamade U, Kuhnt U, Gerber J, Nau R. Differential regulation of Toll-like receptor mRNAs in experimental murine central nervous system infections. Neurosci Lett. 2003;344:17–20. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 HL071837-01A1/HL/NHLBI NIH HHS/United States
- R01 HL071837/HL/NHLBI NIH HHS/United States
- R01 HL071837-02/HL/NHLBI NIH HHS/United States
- R01 HL071837-03/HL/NHLBI NIH HHS/United States
- GM 53552/GM/NIGMS NIH HHS/United States
- R01 HL071837-04/HL/NHLBI NIH HHS/United States
- R01 HL 071837/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous